What You Should Know:
– Veeva Systems has announced a new collaboration with Amgen, a global leader in biotechnology, to advance clinical trial innovation.
– Amgen will use the Veeva Clinical Platform to find and implement efficiencies across its clinical trial processes.
Connected Platform for Clinical Development
The Veeva Clinical Platform is a complete and connected platform that covers clinical operations and data applications. This end-to-end platform includes various tools like CTMS, EDC, clinical workbench (CDB), RTSM, eCOA, eTMF, Site Connect, and Study Training. These connected products are designed to streamline clinical trials from start-up to close and automate a connected data flow. As part of the collaboration, Veeva Business Consulting will support Amgen through the implementation and change management processes.
“In collaboration with Veeva, we’re leveraging advanced technology to unlock new capabilities for our end-to-end trial operations which are expected to further strengthen our ability to bring innovative treatments to patients with speed and scale,” said Scott Skellenger, senior vice president and chief information officer at Amgen.
